ACHILLION PHARMACEUTICALS, INC...
NASDAQ: ACHN
$0.40
+$0.00 (+0.0%)
Closing price May 17, 2022
Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.
2 years ago
Last Updated: 2 years ago
Achillion Pharma shares jumped on Wednesday after the firm announced that the FDA has granted Breakthrough Therapy designation for danicopan (ACH-4471).
2 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,...
3 years ago
Last Updated: 2 years ago
TrovaGene, Range Resources, Achillion Pharma, and Colony NorthStar all posted new 52-week lows on Friday.
4 years ago
Last Updated: 2 years ago
Achillion Pharmaceuticals saw its shares make a handy gain on Thursday after the company announced a secondary offering.
4 years ago
Last Updated: 2 years ago
Achillion Pharmaceuticals saw its shares slump early on Monday after the firm announced that its hepatitis C license and collaboration agreement with Janssen had been terminated.
4 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and other research calls from Thursday include Cisco, Expedia, Exxon, First Solar, Noble, Shake Shack and Symantec.
5 years ago
Last Updated: 2 years ago
24/7 Wall Street takes a look at Facebook and a few other companies posting some of the largest losses for the past week.
5 years ago
Last Updated: 2 years ago
Cult stocks can fall from grace rather quickly — even if they haven't been in the good grace of the trading gods for some time.
5 years ago
Last Updated: 2 years ago
The week of September 23 brought numerous analyst upgrades and downgrades in the biotech and biohealth space.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and Yum Brands.
5 years ago
Last Updated: 2 years ago
24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.
5 years ago
Last Updated: 2 years ago
Here are five stocks trading under $10 with massive analyst upside targets from the week of July 1.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Bank of America, First Solar, KKR, On Deck Capital, Red Hat and Shake Shack.
5 years ago
Last Updated: 2 years ago
The top analyst upgrades, downgrades and initiations seen from Friday, February 26, include American Water Works, Autodesk, Kraft Heinz, Palo Alto Networks, Toyota and Vipshop.
6 years ago
Last Updated: 2 years ago